gadopentetate dimeglumine (Magnevist, Resovist)

Introduction

Tradename: Magnevist.

Indications

• head imaging
  • contrast enhancement used with magnetic resonance imaging in patients with intracranial lesions with abnormal vascularity or lesions thought to affect the blood-brain barrier

Injection: 470 mg/mL (10 mL, 15 mL, 20 mL)

Adverse effects

• hypotension
• headache
• dizziness
• seizures
• nausea
• tinnitus

More general terms

• gadolinium contrast (Omniscan)

Database

• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=55466
• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=157429